Share

News kindly supplied by Goran Ilic through FAPG

University of Oxford - Department of Physiology, Anatomy and Genetics, Laboratory of Molecular Neurodegeneration

Sunday, 29 August 2010 - Applications are invited for a postdoctoral research assistant to join Dr Wade-Martins' Laboratory of Molecular Neurodegeneration to work on the development of novel molecular and genetic therapeutic strategies to better understand and ultimately treat the inherited neurological disease Friedreich's ataxia (FA). Dr Wade-Martins' laboratory is part of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS), a major new European Union-funded initiative to develop new therapies for FA which is funding the post.

EFACTS brings together fourteen academic laboratories across Europe to develop a translational research strategy to better understand and ultimately cure the FA. Our laboratory has pioneered new technologies for the expression of whole genomic DNA loci to better understand the molecular mechanisms of disease. We have previously developed viral and non-viral systems to deliver and express disease-related genes from bacterial artificial chromosome (BAC)-based vectors.

Source/read more